Close
CDMO Safety Testing 2026
Novotech

Press Releases

Quanticate partners with Cancer Research UK to launch DETERMINE Study

Quanticate, a global data-focused clinical research organisation (CRO), has partnered with leading cancer research organisation, Cancer Research UK, to launch the DETERMINE study which will test a range of therapies specifically targeting key genetic changes in cancer cells. The first...

Monon Bioventures receives nearly $400,000 to develop Purdue-discovered glioblastoma treatment

Monon Bioventures LLCย has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR, grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at theย Purdue University College of Pharmacy. โ€œGlioblastoma is one...

Debut Event Showcases Newest Trends in Drug Manufacturing and Delivery

Connect in Pharma โ€” the new annual event from Easyfairs โ€” had its debut launch on 14 & 15 September in Geneva. Key players from companies in the pharmaceutical industry, including Bayer, Merck, Pfizer, Roche, Johnson & Johnson and...

Abzena strengthens R&D capabilities to support rapid antibody discovery

Abzena, a leading CDMO providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a significant upgrade to its research and development capabilities in Cambridge. This includes an investment in B cell discovery technologies...

Bora Pharmaceuticals partners with TaiRx, Inc. to manufacture breakthrough anticancer drug

Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a premier Taiwan new drug development company, to manufacture a novel anticancer drug, CVM-1118. CVM-1118 is a new small molecule chemical entity being developed by...

Peli BioThermal Opens New Service Center In Japan

Peli BioThermal, the life science industryโ€™s partner from discovery to distribution, announces the opening of its new service center in Japan. The new facility, which is the latest location to be added to the companyโ€™s growing network in Asia,...

MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea

MedPharm, a global provider of contract topical and transdermal formulation development and manufacturing services, is pleased to announce that it will support Swiss Biotech company, Mosanna Therapeutics, in the development of a nasal spray (MOS-118) aimed at treating Metabolic...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป